A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
Reports record revenue of $17.6 million for the first quarter of 2024.Reports GAAP diluted EPS of $0.32 and non-GAAP diluted EPS of $0.36 for the first quarter of 2024.Reports first quarter of 2024 operating income of $4.7 million, an increase of 18.5 percent compared...
WINTER SPRINGS, Fla., April 25, 2024 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market opens on Thursday, May 2, 2024. Iradimed management will host a conference call the...
WINTER SPRINGS, Fla., March 13, 2024 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) today announced that Roger Susi, the Company's President and Chief Executive Officer, will present at the 36th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is...
Reports record revenue of $17.5 million for the fourth quarter and $65.6 million for the full year of 2023. Reports GAAP diluted EPS of $0.36 and non-GAAP diluted EPS of $0.39 for the fourth quarter of 2023. Reports GAAP diluted EPS of $1.35 and non-GAAP diluted EPS...
WINTER SPRINGS, Fla., Feb. 01, 2024 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 fourth quarter financial results before the market opens on Thursday, February 8, 2024. Iradimed management will host a conference call...
Reports preliminary fourth quarter 2023 revenue of $17.5 million WINTER SPRINGS, Fla., Jan. 09, 2024 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), a leader in developing innovative Magnetic Resonance Imaging ('MRI") compatible medical devices, today reported...
WINTER SPRINGS, Fla., Jan. 02, 2024 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), a leader in developing innovative Magnetic Resonance Imaging ("MRI") compatible medical devices, today announced that the Company will be participating in the upcoming 42nd...
WINTER SPRINGS, Fla., Dec. 12, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) announced today that its Board of Directors approved a special cash dividend of $0.48 per share and the initiation of a regular quarterly dividend on the Company's outstanding...
WINTER SPRING, Fla., Nov. 30, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) was recently named on Forbes' latest list of America's Most Successful Small-Cap Companies for 2024. Iradimed is a leader in the development of innovative magnetic resonance...
Reports record revenue of $16.5 million for the third quarter of 2023.GAAP diluted EPS of $0.40 and non-GAAP diluted EPS of $0.43.Third quarter operating income of $5.9 million, an increase of 43% compared to the same period in 2022. WINTER SPRINGS, Fla., Nov. 03,...